Guangzhou Wondfo Biotech News and Activities

Guangzhou Wondfo Biotech is a company listed under the stock ticker 300482 (CN).

View the org chart displaying its 7 main executives

Most searched biographies at Guangzhou Wondfo Biotech

• Zhongxiong Peng, General Manager, Director
• Congdong Li, Independent Director
• Jihua Wang, Chairman of the Board

Create your alert
to follow the executive moves at Guangzhou Wondfo Biotech.

Guangzhou Wondfo Biotech has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Guangzhou Wondfo Biotech

Social media about Guangzhou Wondfo Biotech

• Guangzhou Wondfo Biotech on Wikipedia, Google News & Yahoo Finance
• Guangzhou Wondfo Biotech on LinkedIn, X (Twitter) & YouTube